Impact of Exercise Training on Single Ventricle Function in Paediatric Fontan Patients

NCT ID: NCT05617534

Last Updated: 2022-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-10

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about how a prescribed Exercise Training Program would affect children living with a Fontan circulation.

From birth, the children who are born with single functioning ventricle will undergo 3-staged Fontan surgery to achieve a unique Fontan circulation, supported by one functioning ventricle. With advancement in surgical technique and medical care, there are increasing number of children living with Fontan circulating surviving into adulthood.

A significant number of these individuals develop complications in their adulthood due to problems related to this unique circulation, including reduced exercise tolerance, heart failure, abnormal heart rhythm or premature death. Many of these children have acquired sedentary lifestyle, and may have lower self-perceived health related quality of life.

Exercise training is a well-established therapy used in adult population with heart failure. It has been shown to be safe in children with congenital heart disease and with Fontan circulation, it improves their aerobic exercise capacity which is associated with better outcomes.

The main question\[s\] it aims to answer are the impact of a Exercise Training program on:

1. Single ventricle function
2. Exercise capacity
3. Self-perceived quality of life
4. Skeletal muscle mass

Participants will be given a 20-weeks exercise program, 3 sessions of 30 minutes workout weekly, to carry out at home. The following tests will be performed prior to starting and upon completion of the exercise program:

* Echocardiogram
* Cardiopulmonary exercise test
* Body composition scan using a bio-impedance analyser
* Quality of life questionnaires

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Univentricular Heart

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Fontan Exercise Training Ventricular Function Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Fontan circulation, age range 8 to 18 years
* Ability to perform a cardiopulmonary exercise stress test (CPET)
* Free from acute or chronic respiratory illness and/or conditions that might affect exercise performance
* Who have had a Fontan operation at least six months prior.

Exclusion Criteria

* Existing neuro-disability i.e. with paresis post cerebrovascular accident
* Neurodevelopmental issue with inability to comply with commands.
* Documented life-threatening arrhythmia without implantable cardioverter defibrillator
* Moderate or severe atrio-ventricular valve regurgitation
* Moderate or severe ventricular dysfunction by echocardiography exams
* Acute inflammatory cardiac disease
* documented coronary artery stenosis and/or myocardial ischaemia
* Heart failure requiring hospitalisation in the past year
* Evidence of systemic venous pathway obstruction by echocardiography or catheterisation
* Resting oxygen saturation \< 90%
* Systemic ventricular outflow tract stenosis with peak resting systolic gradient \> 50mmHg
Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CHI Research & Innovation Office

UNKNOWN

Sponsor Role collaborator

Children's Health Ireland

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Adam James

Consultant Paediatric Cardiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam James, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Health Ireland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Health Ireland

Dublin, , Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li Yen Ng, MB BCh BAO

Role: CONTACT

Phone: +353862341835

Email: [email protected]

Adam James, MD

Role: CONTACT

Phone: +353871925275

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Li Yen Ng, MB BCh BAO

Role: primary

Adam James, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RSFG-21-ACC13

Identifier Type: -

Identifier Source: org_study_id